LMP Capital and Income Fund (SCD) offers a fairly diversified portfolio but is more uniquely positioned, with its largest allocations being to MLPs and technology sectors. The fund's discount has ...
Heightened market volatility presents unique buying opportunities for income investors, particularly in the technology and energy sectors, which show signs of bottoming as Q1 earnings season ...
This new economic valuation of the societal and health care benefits of gene therapy to treat sickle cell disease (SCD) concludes the highly personalized treatment has potential to be cost effective ...